Prostate cancer is prostate cancer. Prostate cancer is a malignant disease for which the survival rate cannot be described by a single number, but is generally said to be the 5-year survival rate for this disease. This value has a lot to do with the stage of the disease. Early stage prostate cancer has a high 5-year survival rate, which can reach 99% or higher. The more advanced the staging, the lower the 5-year survival rate. Studies suggest that the 5-year survival rate for most men with localized or regional prostate cancer is close to 100%. 98% of patients are still alive after 10 years. For men whose prostate has metastasized, the 5-year survival rate is 30 percent. This statistic actually coincides with staging. It indicates that the earlier the detection and treatment of prostate cancer the better the chances of long-term survival. Since this disease rarely occurs in young people, it mostly occurs in older and frail patients. These patients may have more underlying diseases, and these factors may also affect the survival rate. If the prostate cancer is not severe, but is associated with severe hypertension, heart disease, or cerebrovascular disease, then the 5-year survival rate for these patients may not be as high as the above figures. The survival rate of prostate cancer is related to the stage of the disease, early or late treatment, and the quality of the body itself.